These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19817315)

  • 21. A critical evaluation of a nicotine vaccine within a self-administration behavioral model.
    Moreno AY; Azar MR; Warren NA; Dickerson TJ; Koob GF; Janda KD
    Mol Pharm; 2010 Apr; 7(2):431-41. PubMed ID: 20104903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies.
    LeSage MG; Keyler DE; Pentel PR
    AAPS J; 2006 Feb; 8(1):E65-75. PubMed ID: 16584135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting nicotine addiction: the possibility of a therapeutic vaccine.
    Escobar-Chávez JJ; Domínguez-Delgado CL; Rodríguez-Cruz IM
    Drug Des Devel Ther; 2011; 5():211-24. PubMed ID: 21607018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotine conjugate vaccines: A novel approach in smoking cessation.
    Kitchens CM; Foster SL
    J Am Pharm Assoc (2003); 2012; 52(1):116-8. PubMed ID: 22257625
    [No Abstract]   [Full Text] [Related]  

  • 25. Nicotine conjugate vaccine: is there a right to a smoking future?
    Hasman A; Holm S
    J Med Ethics; 2004 Aug; 30(4):344-5. PubMed ID: 15289514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicotine vaccines.
    Fahim RE; Kessler PD; Fuller SA; Kalnik MW
    CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):905-15. PubMed ID: 22229310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density.
    Zhao Z; Powers K; Hu Y; Raleigh M; Pentel P; Zhang C
    Biomaterials; 2017 Apr; 123():107-117. PubMed ID: 28167389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue-dependent effects of immunization with a nicotine conjugate vaccine on the distribution of nicotine in rats.
    Satoskar SD; Keyler DE; LeSage MG; Raphael DE; Ross CA; Pentel PR
    Int Immunopharmacol; 2003 Jul; 3(7):957-70. PubMed ID: 12810353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment and prevention of tobacco addiction. Antinicotinic vaccine].
    Fernández PL
    An R Acad Nac Med (Madr); 2012; 129(1):295-304; discussion 304-6. PubMed ID: 24294730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of vaccines to help treat drug dependence.
    Bunce CJ; Loudon PT; Akers C; Dobson J; Wood DM
    Curr Opin Mol Ther; 2003 Feb; 5(1):58-63. PubMed ID: 12669472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats.
    LeSage MG; Keyler DE; Hieda Y; Collins G; Burroughs D; Le C; Pentel PR
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):409-16. PubMed ID: 15991003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-nicotine abuse vaccines in the pipeline: an update.
    Cerny EH; Cerny T
    Expert Opin Investig Drugs; 2008 May; 17(5):691-6. PubMed ID: 18447595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotine vaccines to treat tobacco dependence.
    Goniewicz ML; Delijewski M
    Hum Vaccin Immunother; 2013 Jan; 9(1):13-25. PubMed ID: 23108361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced-nicotine content cigarettes: Is there potential to aid smoking cessation?
    Walker N; Bullen C; McRobbie H
    Nicotine Tob Res; 2009 Nov; 11(11):1274-9. PubMed ID: 19793786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing the Immune Response of a Nicotine Vaccine with Synthetic Small "Non-Natural" Peptides.
    Le HT; Fraleigh NL; Lewicky JD; Boudreau J; Dolinar P; Bhardwaj N; Diaz-Mitoma F; Montaut S; Fallahi S; Martel AL
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32178357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies.
    Oliver JL; Pashmi G; Barnett P; Mettens P; Biemans R; Monteyne P; Palmantier R; Gallagher T; Ramaya S; Wonnacott S
    Vaccine; 2007 Oct; 25(42):7354-62. PubMed ID: 17870213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trial watch: Xenova's TA-NIC vaccine shows promise.
    Expert Rev Vaccines; 2004 Aug; 3(4):386. PubMed ID: 15270640
    [No Abstract]   [Full Text] [Related]  

  • 38. A vaccine for nicotine dependence: targeting the drug rather than the brain.
    Pentel P; Malin D
    Respiration; 2002; 69(3):193-7. PubMed ID: 12097758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NicVAX (Nabi Biopharmaceuticals).
    Heading CE
    IDrugs; 2003 Dec; 6(12):1178-81. PubMed ID: 14666429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of passive immunization with nicotine-specific antibodies on the acute and chronic distribution of nicotine to brain in rats.
    Pentel PR; Dufek MB; Roiko SA; Lesage MG; Keyler DE
    J Pharmacol Exp Ther; 2006 May; 317(2):660-6. PubMed ID: 16407464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.